Diastolic timed Vibro-Percussion at 50 Hz delivered across a chest wall sized meat barrier enhances clot dissolution and remotely administered Streptokinase effectiveness in an in-vitro model of acute coronary thrombosis.

Diastolic timed Vibro-Percussion at 50 Hz delivered across a chest wall sized meat barrier enhances clot dissolution and remotely administered Streptokinase effectiveness in an in-vitro model of acute coronary thrombosis.
复制标题

DOI:
10.1186/1477-9560-10-23
复制
发表时间:
2012-11-12
期刊:
影响因子:
3.1
通讯作者:
Gill H
Gill H
中科院分区:
医学3区
文献类型:
--
作者:
Hoffmann A;Gill H

文献摘要

被引文献

相似文献

低频振动-冲击(LFVP)有助于清除导管系统中的血栓,并且当应用于心脏并定时至血栓时,已知可增强冠状动脉血流。然而,需要研究在胸壁大小的屏障上接合的凝块冠状动脉样血管上的LFVP(类似于非侵入性心脏病发作治疗)。将1小时前的凝块(n=16)分配在Soft-Flo导管(4 mm管腔)的柔性段内,称重,与肝素化盐水(HS)连接,固定在弯曲的阻尼底座上,并拍照。将约4cm的肉板放置在节段上,并随机接受间歇性LFVP(以1秒间隔接合,-脱离)或无LFVP 20分钟。对HS进行脉冲(~120/80 mmHg),舒张期相协调以匹配LFVP输送。然后对节段重新拍照并吸出液体以确定凝块后重量。然后重复试验,在凝块上游约2 cm处递送0.5 ml链激酶(15,000 IU/100微升)。仅LFVP-HS样品(与对照相比)显示:a)对照组中不存在的凝块长度流体通道的形成(p < 0.0002); B)溶解凝块混合评分增加(5.0 vs. 0.8,p < 2.8 E - 6);和c)凝块溶解百分比增加(分别为23.0% vs. 1.8%,p < 8.5 E-6)。LFVP-SK样品具有类似的比较性凝块破坏特征,然而流体通道发展更快,并且凝块溶解百分比增加一倍以上(51.0%对3.0%,p<9.8E- 6)。舒张期定时LFVP(50 Hz)穿过胸壁大小的屏障,增强了对潜在冠状动脉样系统的凝块破坏作用。
Low Frequency Vibro-Percussion (LFVP) assists clearance of thrombi in catheter systems and when applied to the heart and timed to diastole is known to enhance coronary flow. However LFVP on a clotted coronary like vessel given engagement over a chest wall sized barrier (to resemble non-invasive heart attack therapy) requires study. One hour old clots (n=16) were dispensed within a flexible segment of Soft-Flo catheter (4 mm lumen), weighted, interfaced with Heparinized Saline (HS), secured atop a curved dampening base, and photographed. A ~4 cm meat slab was placed over the segment and randomized to receive intermittent LFVP (engaged, - disengaged at 1 second intervals), or no LFVP for 20 minutes. HS was pulsed (~120/80 mmHg), with the diastolic phase coordinated to match LFVP delivery. The segment was then re-photographed and aspirated of fluid to determine post clot weight. The trial was then repeated with 0.5 mls of Streptokinase (15,000 IU/100 microlitre) delivered ~ 2 cm upstream from the clot. LFVP - HS only samples (vs. controls) showed; a) development of clot length fluid channels absent in the control group (p < 0.0002); b) enhanced dissolved clot mixing scores ( 5.0 vs. 0.8, p < 2.8 E – 6); and c) increased percent clot dissolution (23.0% vs. 1.8% respectively, p < 8.5 E-6). LFVP - SK samples had a similar comparative clot disruptive profile, however fluid channels developed faster and percent clot dissolution more than doubled (51.0% vs. 3.0%, p< 9.8 E- 6). Diastolic timed LFVP (50 Hz) engaged across a chest wall sized barrier enhances clot disruptive effects to an underlying coronary like system.